Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Darovasertib by Ideaya Biosciences for Metastatic Uveal Melanoma: Likelihood of Approval
Darovasertib is under clinical development by Ideaya Biosciences and currently in Phase III for Metastatic Uveal Melanoma. According to GlobalData,...